Table 3.
Outcome | EAM only (n=3238) | EAM+TEE (N=2563) | EAM+CT/MRI (N=2227) | EAM+CT/MRI+TEE (N=3497) | p Value |
---|---|---|---|---|---|
Mortality | 54 (1.9%) | 37 (1.6%) | 23 (1.1%) | 32 (1.0%) | 0.03 |
Composite, overall (excluding mortality)*† |
138 (4.5%) | 121 (5.1%) | 71 (3.4%) | 123 (3.8%) | 0.02 |
Stroke/TIA | 30 (1.0%) | 19 (0.8%) | * | 14 (0.4%) | 0.009 |
Severe bleeding‡ | 27 (0.8%) | 28 (1.1%) | 24 (1.1%) | 31 (0.9%) | 0.67 |
Repeat ablation | 177 (6.2%) | 148 (6.7%) | 154 (7.9%) | 177 (6.0%) | 0.03 |
Composite, cardiovascular§ | 114 (3.8%) | 96 (4.1%) | 50 (2.4%) | 93 (2.9%) | 0.005 |
10 or fewer patients in this cell
Includes stroke/TIA, haemopericardium, cardiac tamponade, heart failure and vascular complications requiring surgery.
Includes haemopericardium, cardiac tamponade and vascular complications requiring surgery.
Includes stroke/TIA, myocardial infarction and heart failure.
EAM, electroanatomic mapping; TEE, transoesophageal echocardiogram; TIA, transient ischaemic attack.